These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2201691)

  • 21. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
    Lee SK; Potempa M; Kolli M; Özen A; Schiffer CA; Swanstrom R
    J Biol Chem; 2012 Apr; 287(16):13279-90. PubMed ID: 22334652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.
    Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions.
    Rosé JR; Salto R; Craik CS
    J Biol Chem; 1993 Jun; 268(16):11939-45. PubMed ID: 8505318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol.
    Ogata M; Fryling CM; Pastan I; FitzGerald DJ
    J Biol Chem; 1992 Dec; 267(35):25396-401. PubMed ID: 1460035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.
    Tözsér J; Bláha I; Copeland TD; Wondrak EM; Oroszlan S
    FEBS Lett; 1991 Apr; 281(1-2):77-80. PubMed ID: 2015912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescent oligopeptide substrates for kinetic characterization of the specificity of Astacus protease.
    Stöcker W; Ng M; Auld DS
    Biochemistry; 1990 Nov; 29(45):10418-25. PubMed ID: 2261483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.
    Sawyer TK; Staples DJ; Liu L; Tomasselli AG; Hui JO; O'Connell K; Schostarez H; Hester JB; Moon J; Howe WJ
    Int J Pept Protein Res; 1992; 40(3-4):274-81. PubMed ID: 1478785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
    Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
    J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. Effects on hydrolysis by HIV-1 proteinase.
    Jupp RA; Phylip LH; Mills JS; Le Grice SF; Kay J
    FEBS Lett; 1991 Jun; 283(2):180-4. PubMed ID: 2044756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
    Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
    J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
    Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
    J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The primary structure of human liver manganese superoxide dismutase.
    Barra D; Schinina ME; Simmaco M; Bannister JV; Bannister WH; Rotilio G; Bossa F
    J Biol Chem; 1984 Oct; 259(20):12595-601. PubMed ID: 6386798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical synthesis of a biotinylated derivative of the simian immunodeficiency virus protease. Purification by avidin affinity chromatography and autocatalytic activation.
    Tomasselli AG; Bannow CA; Deibel MR; Hui JO; Zurcher-Neely HA; Reardon IM; Smith CW; Heinrikson RL
    J Biol Chem; 1992 May; 267(15):10232-7. PubMed ID: 1587812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.
    Menéndez-Arias L; Weber IT; Soss J; Harrison RW; Gotte D; Oroszlan S
    J Biol Chem; 1994 Jun; 269(24):16795-801. PubMed ID: 8207003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases.
    Fan N; Rank KB; Leone JW; Heinrikson RL; Bannow CA; Smith CW; Evans DB; Poppe SM; Tarpley WG; Rothrock DJ
    J Biol Chem; 1995 Jun; 270(22):13573-9. PubMed ID: 7539431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of the wound-induced leucine aminopeptidase (LAP-A) of tomato activity on dipeptide and tripeptide substrates.
    Gu YQ; Walling LL
    Eur J Biochem; 2000 Feb; 267(4):1178-87. PubMed ID: 10672029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrate specificities and inhibition of two hemorrhagic zinc proteases Ht-c and Ht-d from Crotalus atrox venom.
    Fox JW; Campbell R; Beggerly L; Bjarnason JB
    Eur J Biochem; 1986 Apr; 156(1):65-72. PubMed ID: 3514216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
    Tomasselli AG; Heinrikson RL
    Methods Enzymol; 1994; 241():279-301. PubMed ID: 7854182
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.